Wolverine Asset Management’s Immunocore IMCR Stock Holding History

Wolverine Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,800	Closed	-$386K	–	1764
2026 Q1	$386K	Hold	12,800	–	–	﹤0.01%	976
2025 Q4	$444K	Sell	12,800 -4,000	-24%	-$141K	﹤0.01%	956
2025 Q3	$610K	Buy	16,800 +12,800	+320%	+$435K	﹤0.01%	833
2025 Q2	$126K	Hold	4,000	–	–	﹤0.01%	1087
2025 Q1	$119K	Hold	4,000	–	–	﹤0.01%	1078
2024 Q4	$118K	Sell	4,000 -27,100	-87%	-$857K	﹤0.01%	1095
2024 Q3	$968K	Buy	31,100 +4,300	+16%	+$156K	0.01%	713
2024 Q2	$908K	Buy	+26,800	New	+$1.37M	0.01%	699

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Wolverine Asset Management's IMCR Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in Immunocore (IMCR) in Q2 2026: 2,822 shares worth $89.6K. The stake represents ﹤0.01% of the portfolio and ranks #1179 among its holdings. This is a return to the name: Wolverine Asset Management previously reported a position in IMCR as recently as Q3 2024.

Wolverine Asset Management first reported a position in IMCR in Q3 2024 and has held it in 2 quarters since. The position peaked at $589K in Q3 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Wolverine Asset Management held 2,822 shares of Immunocore worth $89.6K as of Q2 2026.
Immunocore was a new Wolverine Asset Management position in Q2 2026.
Immunocore made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1179 holding.
Wolverine Asset Management first reported a position in Immunocore in Q3 2024 and has held it in 2 quarters since.
Wolverine Asset Management's Immunocore position peaked at $589K in Q3 2024.
135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.